NASDAQ:YTEN - Yield10 Bioscience Stock Price, Price Target & More

$1.6865 0.00 (0.00 %)
(As of 04/23/2018 04:00 PM ET)
Previous Close$1.6865
Today's Range$1.6298 - $1.70
52-Week Range$1.44 - $9.30
Volume82,706 shs
Average Volume948,223 shs
Market Capitalization$16.80 million
P/E Ratio-0.51
Dividend YieldN/A
Beta3.18

About Yield10 Bioscience (NASDAQ:YTEN)

Yield10 Bioscience logoYield10 Bioscience, Inc., an agricultural bioscience company, engages in developing disruptive technologies for enhancing crop yield in the United States and Canada. The company, through its Smart Carbon Grid for Crops and T3 platforms is involved in improving fundamental crop yield through enhanced photosynthetic carbon capture, as well as increased carbon utilization efficiency to increase seed yield. The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was founded in 1992 and is headquartered in Woburn, Massachusetts.

Receive YTEN News and Ratings via Email

Sign-up to receive the latest news and ratings for YTEN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Miscellaneous plastics products
Sub-IndustryN/A
SectorConsumer Staples
SymbolNASDAQ:YTEN
CUSIPN/A
Phone617-583-1700

Debt

Debt-to-Equity Ratio0.08%
Current Ratio6.29%
Quick Ratio6.29%

Price-To-Earnings

Trailing P/E Ratio-0.51
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$940,000.00
Price / Sales17.89
Cash FlowN/A
Price / CashN/A
Book Value$1.48 per share
Price / Book1.14

Profitability

EPS (Most Recent Fiscal Year)($3.29)
Net Income$-9,390,000.00
Net Margins-995.34%
Return on Equity-170.60%
Return on Assets-101.58%

Miscellaneous

Employees20
Outstanding Shares9,970,000

How to Become a New Pot Stock Millionaire

Yield10 Bioscience (NASDAQ:YTEN) Frequently Asked Questions

What is Yield10 Bioscience's stock symbol?

Yield10 Bioscience trades on the NASDAQ under the ticker symbol "YTEN."

When did Yield10 Bioscience's stock split? How did Yield10 Bioscience's stock split work?

Yield10 Bioscience shares reverse split before market open on Tuesday, May 30th 2017. The 1-10 reverse split was announced on Friday, May 26th 2017. The number of shares owned by shareholders was adjusted after the market closes on Friday, May 26th 2017. An investor that had 100 shares of Yield10 Bioscience stock prior to the reverse split would have 10 shares after the split.

How were Yield10 Bioscience's earnings last quarter?

Yield10 Bioscience, Inc. (NASDAQ:YTEN) posted its quarterly earnings data on Thursday, March, 8th. The specialty chemicals company reported ($0.99) EPS for the quarter. The specialty chemicals company had revenue of $0.10 million for the quarter. Yield10 Bioscience had a negative return on equity of 170.60% and a negative net margin of 995.34%. View Yield10 Bioscience's Earnings History.

Who are some of Yield10 Bioscience's key competitors?

Who are Yield10 Bioscience's key executives?

Yield10 Bioscience's management team includes the folowing people:
  • Dr. Oliver P. Peoples Ph.D., Co-Founder, Pres, CEO & Director (Age 60)
  • Dr. Anthony J. Sinskey, Co-Founder & Director (Age 78)
  • Dr. Kristi Snell Ph.D., Chief Science Officer & VP - Research (Age 50)
  • Ms. Lynne H. Brum, VP - Planning & Communications and Sec. (Age 54)
  • Mr. Charles B. Haaser, Chief Accounting Officer, Principal Financial Officer, VP of Fin. & Treasurer (Age 62)

Has Yield10 Bioscience been receiving favorable news coverage?

Press coverage about YTEN stock has trended somewhat positive on Monday, according to Accern Sentiment Analysis. The research group identifies positive and negative media coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Yield10 Bioscience earned a news sentiment score of 0.22 on Accern's scale. They also gave news stories about the specialty chemicals company an impact score of 45.94 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company's share price in the near future.

How do I buy shares of Yield10 Bioscience?

Shares of YTEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Yield10 Bioscience's stock price today?

One share of YTEN stock can currently be purchased for approximately $1.6865.

How big of a company is Yield10 Bioscience?

Yield10 Bioscience has a market capitalization of $16.80 million and generates $940,000.00 in revenue each year. The specialty chemicals company earns $-9,390,000.00 in net income (profit) each year or ($3.29) on an earnings per share basis. Yield10 Bioscience employs 20 workers across the globe.

How can I contact Yield10 Bioscience?

Yield10 Bioscience's mailing address is 19 PRESIDENTIAL WAY, WOBURN MA, 01801. The specialty chemicals company can be reached via phone at 617-583-1700 or via email at [email protected]


MarketBeat Community Rating for Yield10 Bioscience (YTEN)

Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  76 (Vote Outperform)
Underperform Votes:  127 (Vote Underperform)
Total Votes:  203
MarketBeat's community ratings are surveys of what our community members think about Yield10 Bioscience and other stocks. Vote "Outperform" if you believe YTEN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe YTEN will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Yield10 Bioscience (NASDAQ:YTEN) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
(Data available from 4/23/2016 forward)

Earnings

Yield10 Bioscience (NASDAQ:YTEN) Earnings History and Estimates Chart

Earnings by Quarter for Yield10 Bioscience (NASDAQ:YTEN)

Yield10 Bioscience (NASDAQ:YTEN) Earnings Estimates

Current Year EPS Consensus Estimate: $-4.5 EPS

Yield10 Bioscience (NASDAQ YTEN) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/8/2018Q4 2017($0.99)$0.10 millionViewListenView Earnings Details
11/9/2017Q3 2017($0.59)$0.22 millionViewN/AView Earnings Details
8/10/2017Q2 2017($0.96)$0.29 millionViewN/AView Earnings Details
5/11/2017Q1 2017($0.70)$0.32 millionViewN/AView Earnings Details
3/22/2017Q4 2016($0.60)$0.34 millionViewN/AView Earnings Details
11/9/2016Q116($1.40)($0.50)$0.47 millionViewListenView Earnings Details
8/8/2016Q2 2016($1.20)$2.79 millionViewN/AView Earnings Details
5/16/2016Q1($2.30)($2.40)$0.89 million$0.68 millionViewN/AView Earnings Details
3/29/2016Q415($2.40)($2.20)$0.92 million$0.50 millionViewListenView Earnings Details
11/10/2015Q315($2.60)($2.20)$0.71 millionViewListenView Earnings Details
8/12/2015Q215($2.60)$0.74 millionViewListenView Earnings Details
5/13/2015Q115($0.40)($0.40)$0.65 millionViewListenView Earnings Details
3/19/2015Q414($0.90)($0.50)$0.86 millionViewListenView Earnings Details
11/5/2014Q3 14($1.60)($1.40)$1.10 million$0.63 millionViewListenView Earnings Details
8/6/2014($2.30)($2.10)$1.40 million$1.17 millionViewN/AView Earnings Details
5/14/2014($2.10)($2.30)$1.25 million$1.07 millionViewN/AView Earnings Details
3/27/2014($2.10)($2.50)$0.80 million$0.89 millionViewN/AView Earnings Details
11/5/2013Q3 13($2.40)($2.10)$1.70 million$0.86 millionViewN/AView Earnings Details
7/31/2013Q2 2013($2.00)($2.30)$1.57 million$1.71 millionViewN/AView Earnings Details
5/8/2013Q1 2013($2.50)($2.00)$1.43 million$1.94 millionViewN/AView Earnings Details
3/26/2013Q4 2012($2.60)($2.80)$1.23 million$1.40 millionViewN/AView Earnings Details
11/1/2012($2.40)($2.30)ViewN/AView Earnings Details
7/26/2012($2.60)($2.30)ViewN/AView Earnings Details
4/26/2012$8.40$8.40ViewN/AView Earnings Details
3/6/2012($3.00)($2.80)ViewN/AView Earnings Details
11/1/2011($2.90)($2.80)ViewN/AView Earnings Details
7/27/2011($3.30)($3.30)ViewN/AView Earnings Details
4/27/2011($3.60)($3.60)ViewN/AView Earnings Details
3/9/2011($3.70)($3.50)ViewN/AView Earnings Details
11/8/2010Q3 2010($19.80)($22.32)ViewN/AView Earnings Details
7/28/2010Q2 2010($18.60)($21.36)ViewN/AView Earnings Details
4/28/2010Q1 2010($18.00)($22.20)ViewN/AView Earnings Details
3/10/2010Q4 2009($28.19)($23.64)ViewN/AView Earnings Details
10/29/2009Q3 2009($27.59)($24.54)ViewN/AView Earnings Details
7/29/2009Q2 2009($26.39)($25.25)ViewN/AView Earnings Details
5/6/2009Q1 2009($25.19)($23.76)ViewN/AView Earnings Details
3/11/2009Q4 2008($24.60)($24.00)ViewN/AView Earnings Details
11/5/2008Q3 2008($24.00)($25.43)ViewN/AView Earnings Details
8/11/2008Q2 2008($21.60)($23.52)ViewN/AView Earnings Details
5/7/2008Q1 2008($19.80)($22.38)ViewN/AView Earnings Details
3/11/2008Q4 2007($24.00)($19.80)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Yield10 Bioscience (NASDAQ:YTEN) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Yield10 Bioscience (NASDAQ YTEN) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 5.80%
Institutional Ownership Percentage: 9.29%
Insider Trading History for Yield10 Bioscience (NASDAQ:YTEN)
Insider Trading History for Yield10 Bioscience (NASDAQ:YTEN)

Yield10 Bioscience (NASDAQ YTEN) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/13/2016William P ScullyMajor ShareholderSell68,333$0.33$22,549.892,956,666View SEC Filing  
9/9/2016William P ScullyMajor ShareholderSell165,000$0.35$57,750.003,066,666View SEC Filing  
9/17/2015William P ScullyMajor ShareholderBuy31,833$2.11$67,167.633,167,016View SEC Filing  
9/15/2015William P. Scullymajor shareholderBuy67,500$2.16$145,800.003,135,183View SEC Filing  
9/10/2015William P ScullyMajor ShareholderBuy25,000$2.71$67,750.003,067,683View SEC Filing  
9/8/2015William P ScullyMajor ShareholderBuy40,000$2.23$89,200.003,042,683View SEC Filing  
9/4/2015William P. Scullymajor shareholderBuy42,750$2.15$91,912.503,002,683View SEC Filing  
8/28/2015William P ScullyMajor ShareholderBuy26,600$1.99$52,934.002,959,933View SEC Filing  
6/19/2015Birchview Capital Gp, LlcDirectorBuy43,700$3.32$145,084.00View SEC Filing  
6/19/2015Family Foundation SchulerMajor ShareholderBuy1,664,840$3.32$5,527,268.80View SEC Filing  
6/19/2015Joseph H ShaulsonCEOBuy35,000$3.32$116,200.00View SEC Filing  
6/19/2015Lynne H BrumVPBuy14,570$3.32$48,372.40View SEC Filing  
6/19/2015Walsem Johan VanCOOBuy12,000$3.32$39,840.00View SEC Filing  
11/29/2013Matthew StrobeckDirectorBuy100,000$1.00$100,000.00705,000View SEC Filing  
12/3/2012Richard P EnoCEOBuy20,000$1.17$23,400.00View SEC Filing  
11/30/2012Nostrand Robert L VanDirectorBuy20,000$1.07$21,400.00View SEC Filing  
11/30/2012Oliver P PeoplesVPBuy40,000$1.07$42,800.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Yield10 Bioscience (NASDAQ YTEN) News Headlines

Source:
DateHeadline
SeeThruEquity Issues Update on Yield10 Bioscience, Inc. (Nasdaq CM: YTEN)SeeThruEquity Issues Update on Yield10 Bioscience, Inc. (Nasdaq CM: YTEN)
finance.yahoo.com - March 22 at 9:46 AM
NeuroOne (NMTC) Could Outperform RKDA & YPEN with Near Term FDA Decision & Incredible TechnologyNeuroOne (NMTC) Could Outperform RKDA & YPEN with Near Term FDA Decision & Incredible Technology
finance.yahoo.com - March 15 at 9:26 AM
Today’s Research Reports on Stocks to Watch: Arcadia Biosciences and Yield10 BioscienceToday’s Research Reports on Stocks to Watch: Arcadia Biosciences and Yield10 Bioscience
finance.yahoo.com - March 15 at 9:26 AM
Yield10 Bioscience (YTEN) Releases  Earnings ResultsYield10 Bioscience (YTEN) Releases Earnings Results
www.americanbankingnews.com - March 9 at 11:46 PM
Yield10 Bioscience, Inc. to Host Earnings CallYield10 Bioscience, Inc. to Host Earnings Call
finance.yahoo.com - March 8 at 5:16 PM
Yield10 Bioscience Announces Fourth Quarter and Full Year 2017 Financial ResultsYield10 Bioscience Announces Fourth Quarter and Full Year 2017 Financial Results
finance.yahoo.com - March 8 at 5:16 PM
Yield10 Bioscience (YTEN) Presents At LD Micro Virtual Conference 2018 - SlideshowYield10 Bioscience (YTEN) Presents At LD Micro Virtual Conference 2018 - Slideshow
seekingalpha.com - March 8 at 9:53 AM
Yield10 Bioscience to Present at the Inaugural LD Micro Virtual ConferenceYield10 Bioscience to Present at the Inaugural LD Micro Virtual Conference
finance.yahoo.com - March 1 at 9:13 AM
Yield10 Bioscience to Host Webcast of its 2017 Year-end Conference CallYield10 Bioscience to Host Webcast of its 2017 Year-end Conference Call
finance.yahoo.com - February 28 at 9:27 AM
Yield10 Bioscience Reports Encouraging Results from 2017 Field Tests of Novel Yield Trait Gene C3003 in Camelina and Canola Yield10 Bioscience Reports Encouraging Results from 2017 Field Tests of Novel Yield Trait Gene C3003 in Camelina and Canola 
finance.yahoo.com - January 9 at 10:23 AM
Yield10 Bioscience Inc (NASDAQ:YTEN): Has Recent Earnings Growth Beaten Long-Term Trend?Yield10 Bioscience Inc (NASDAQ:YTEN): Has Recent Earnings Growth Beaten Long-Term Trend?
finance.yahoo.com - December 28 at 12:20 AM
Yield10 Bioscience Announces Closing of $14.5 Million Public OfferingYield10 Bioscience Announces Closing of $14.5 Million Public Offering
finance.yahoo.com - December 21 at 4:29 PM
Yield10 Bioscience Soars on Monsanto License Deal, Technology Review and Market HighlightsYield10 Bioscience Soars on Monsanto License Deal, Technology Review and Market Highlights
finance.yahoo.com - December 12 at 10:57 AM
UPDATE: Yield10 Bioscience, Inc. (YTEN) Climbs 200% After Granting Research License to MonsantoUPDATE: Yield10 Bioscience, Inc. (YTEN) Climbs 200% After Granting Research License to Monsanto
www.streetinsider.com - December 11 at 4:35 PM
Here’s Why Yield10 Bioscience Inc (YTEN) Shares Are Jumping Like a BeanstalkHere’s Why Yield10 Bioscience Inc (YTEN) Shares Are Jumping Like a Beanstalk
finance.yahoo.com - December 11 at 4:35 PM
Reviewing Yield10 Bioscience (YTEN) & PAREXEL International (PRXL)Reviewing Yield10 Bioscience (YTEN) & PAREXEL International (PRXL)
www.americanbankingnews.com - December 11 at 11:24 AM
Yield10 Bioscience CSO Dr. Kristi Snell to Present at CanolaWeek 2017Yield10 Bioscience CSO Dr. Kristi Snell to Present at CanolaWeek 2017
finance.yahoo.com - December 7 at 10:54 AM
Yield10 Bioscience, Inc. :YTEN-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017Yield10 Bioscience, Inc. :YTEN-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017
finance.yahoo.com - November 29 at 10:37 AM
Yield10 Bioscience Announces Adjournment of Special Meeting of StockholdersYield10 Bioscience Announces Adjournment of Special Meeting of Stockholders
finance.yahoo.com - November 29 at 10:37 AM
Contrasting Metabolix (YTEN) & Its PeersContrasting Metabolix (YTEN) & Its Peers
www.americanbankingnews.com - November 25 at 7:12 PM
Are You Backing The Right Horse With Yield10 Bioscience Inc (YTEN)?Are You Backing The Right Horse With Yield10 Bioscience Inc (YTEN)?
finance.yahoo.com - November 16 at 10:11 AM
Yield10 Bioscience Announces Third Quarter 2017 Financial ResultsYield10 Bioscience Announces Third Quarter 2017 Financial Results
finance.yahoo.com - November 12 at 1:43 PM
Metabolix, Inc. (YTEN) Posts  Earnings ResultsMetabolix, Inc. (YTEN) Posts Earnings Results
www.americanbankingnews.com - November 10 at 2:34 PM
Comparing Metabolix (YTEN) & Celldex Therapeutics (CLDX)Comparing Metabolix (YTEN) & Celldex Therapeutics (CLDX)
www.americanbankingnews.com - November 8 at 5:28 AM
Yield10 Bioscience to Host Webcast of its Third Quarter 2017 Conference CallYield10 Bioscience to Host Webcast of its Third Quarter 2017 Conference Call
finance.yahoo.com - November 6 at 9:48 AM
Metabolix (YTEN) versus Its Peers Financial ContrastMetabolix (YTEN) versus Its Peers Financial Contrast
www.americanbankingnews.com - November 5 at 5:26 AM
Reviewing Metabolix (YTEN) & ImmunoGen (IMGN)Reviewing Metabolix (YTEN) & ImmunoGen (IMGN)
www.americanbankingnews.com - November 3 at 1:10 AM
Who Are The Largest Shareholders In Yield10 Bioscience Inc (YTEN)?Who Are The Largest Shareholders In Yield10 Bioscience Inc (YTEN)?
finance.yahoo.com - November 2 at 11:54 AM
Yield10 Bioscience, Inc. :YTEN-US: Earnings Analysis: Q2, 2017 By the Numbers : October 4, 2017Yield10 Bioscience, Inc. :YTEN-US: Earnings Analysis: Q2, 2017 By the Numbers : October 4, 2017
finance.yahoo.com - October 4 at 1:28 PM
Yield10 Bioscience to Participate in U.S. Department of Energy Grant for Boosting Oilseed Yield in CamelinaYield10 Bioscience to Participate in U.S. Department of Energy Grant for Boosting Oilseed Yield in Camelina
finance.yahoo.com - September 15 at 11:57 AM
Yield10 Bioscience Obtains Confirmation of Nonregulated Status from USDA-APHIS for its Genome-edited Camelina LineYield10 Bioscience Obtains Confirmation of Nonregulated Status from USDA-APHIS for its Genome-edited Camelina Line
www.nasdaq.com - September 5 at 3:34 PM
Yield10 Bioscience Obtains Confirmation of Nonregulated Status from USDA-APHIS for its Genome-edited Camelina LineYield10 Bioscience Obtains Confirmation of Nonregulated Status from USDA-APHIS for its Genome-edited Camelina Line
finance.yahoo.com - September 5 at 3:34 PM
Metabolix, Inc. (NASDAQ:YTEN) Releases Quarterly  Earnings ResultsMetabolix, Inc. (NASDAQ:YTEN) Releases Quarterly Earnings Results
www.americanbankingnews.com - August 11 at 11:50 AM
Yield10 Bioscience Announces Second Quarter 2017 Financial ResultsYield10 Bioscience Announces Second Quarter 2017 Financial Results
finance.yahoo.com - August 11 at 9:21 AM
Yield10 Bioscience Announces Collaboration with National Research Council of Canada to Improve Yield and Drought Tolerance in WheatYield10 Bioscience Announces Collaboration with National Research Council of Canada to Improve Yield and Drought Tolerance in Wheat
finance.yahoo.com - August 9 at 9:31 AM
Yield10 Bioscience to Host Webcast of its Second Quarter 2017 Conference CallYield10 Bioscience to Host Webcast of its Second Quarter 2017 Conference Call
finance.yahoo.com - July 27 at 9:49 AM
Yield10 Bioscience Announces Pricing of $2.3 Million Registered Direct OfferingYield10 Bioscience Announces Pricing of $2.3 Million Registered Direct Offering
finance.yahoo.com - July 3 at 8:43 AM
Yield10 Bioscience Starts Field Tests of Novel Yield Trait Gene C3003 in Oilseed Crops Camelina and CanolaYield10 Bioscience Starts Field Tests of Novel Yield Trait Gene C3003 in Oilseed Crops Camelina and Canola
globenewswire.com - June 9 at 2:56 AM
Yield10 Bioscience, Inc. 2017 Q1 - Results - Earnings Call SlidesYield10 Bioscience, Inc. 2017 Q1 - Results - Earnings Call Slides
seekingalpha.com - May 12 at 3:20 PM
YIELD10 BIOSCIENCE, INC. Files SEC form 10-K, Annual ReportYIELD10 BIOSCIENCE, INC. Files SEC form 10-K, Annual Report
biz.yahoo.com - March 30 at 8:39 PM
YIELD10 BIOSCIENCE, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements andYIELD10 BIOSCIENCE, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
biz.yahoo.com - March 23 at 9:03 AM
YIELD10 BIOSCIENCE, INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsYIELD10 BIOSCIENCE, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
biz.yahoo.com - January 27 at 6:56 AM
YIELD10 BIOSCIENCE, INC. Files SEC form 8-K, Change in Directors or Principal OfficersYIELD10 BIOSCIENCE, INC. Files SEC form 8-K, Change in Directors or Principal Officers
biz.yahoo.com - January 17 at 12:07 PM

SEC Filings

Yield10 Bioscience (NASDAQ:YTEN) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Yield10 Bioscience (NASDAQ:YTEN) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Yield10 Bioscience (NASDAQ YTEN) Stock Chart for Monday, April, 23, 2018

Loading chart…

This page was last updated on 4/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.